Europäisches
Patentamt
European
Office européen
Patent Office des brevets
Principal Directorate Grant Automation
Proposal
Project: C436
Subclass: C12N
22 March 2007
We would like to propose 2 counter-proposals, with the second one being more complete.
Proposal 1:
D
5/06
<transferred to 5/065 and subgroups>
N
5/065
. Animal cells or tissues
N
5/07
. . Vertebrate cells or tissues, including human cells or tissues
N
5/0705
. . . Tumour cells
N
5/0709
. . . . Stem cells; Progenitor cells
N
5/071
. . . Embryonic cells or tissues
N
5/0719
. . . . Pluripotent stem cells, e.g. embryonic stem cells (ES)
N
5/073
. . . Oocytes; Oogonia
N
5/0735
. . . Sperm cells; Spermatogonia
N
5/074
. . . Mesenchymal cells
N
5/0749
. . . . Mesenchymal stem cells
N
5/075
. . . Cells from the blood or the immune system
N
5/0752
. . . . T cells; Progenitors thereof
N
5/0753
. . . . Dendritic cells; Progenitors thereof
N
5/0759
. . . . Stem cells; Multipotent progenitor cells
N
5/076
. . . Neural cells
N
5/0769
. . . . Stem cells; Progenitor cells
D
5/08
<transferred to 5/07 and subgroups>
N
15/111
. . . Non-coding nucleic acids modulating the expression of genes, e.g.
antisenses
N
15/113
. . . Aptamers, i.e. nucleic acids binding a target molecule specifically and
with high affinity without hybridising thereto
N
15/115
. . . Nucleic acids having immunomodulatory properties, e.g. containing
CpG-motifs
N
15/872
. . . Techniques for producing new embryos, e.g. nuclear transfer,
manipulation of totipotent cells, production of chimeric embryos
N
15/8722
. . . . Techniques for producing new mammalian cloned embryos
Proposal 2:
D
5/06
<transferred to 5/065>
N
5/065
. Animal cells or tissues
N
5/07
. . Vertebrate cells or tissues, including human cells or tissues
N
5/0705
. . . Tumour cells
N
5/0709
. . . . Stem cells; Progenitor cells
N
5/071
. . . Embryonic cells or tissues; Foetal cells or tissues
N
5/0719
. . . . Pluripotent stem cells, e.g. embryonic stem cells (ES);
Embryonic germ cells (EG)
N
5/072
. . . Non-embryonic pluripotent stem cells
N
5/073
. . . Oocytes; Oogonia
N
5/0735
. . . Sperm cells; Spermatogonia
N
fat
5/074
. . . Mesenchymal cells, e.g. bone cells, cartilage cells, stromal cells,
cells, muscular cells
N
5/0749
. . . . Mesenchymal stem cells; Adipose-tissue derived stem cells
N
5/075
. . . Cells from the blood or the immune system
N
5/0751
. . . . B cells; Progenitors thereof
N
5/0752
. . . . T cells; NK cells; Progenitors thereof
N
5/0753
. . . . Dendritic cells; Progenitors thereof
N
5/0754
. . . . Monocytes; Macrophages
N
5/0755
. . . . Granulocytes, e.g. basophils, eosinophils, neutrophils, mast
cells
N
5/0759
. . . . Stem cells; Multipotent progenitor cells
N
5/076
. . . Neural cells
N
5/0761
. . . . Neurons
N
5/0769
. . . . Stem cells; Progenitor cells
N
15/111
. . . Non-coding nucleic acids modulating the expression of genes, e.g.
antisenses
N
15/113
. . . Aptamers, i.e. nucleic acids binding a target molecule specifically and
with high affinity without hybridising thereto
N
15/115
. . . Nucleic acids having immunomodulatory properties, e.g. containing
CpG-motifs
D
5/08
<transferred to 5/07 and subgroups>
N
15/872
. . . Techniques for producing new embryos, e.g. nuclear transfer,
manipulation of totipotent cells, production of chimeric embryos
N
15/8722
. . . . Techniques for producing new mammalian cloned embryos
Indexing scheme relating to the specification of the type of nucleic acid of 15/111:
N
101/00
Antisense nucleic acids
N
103/00
Triple helix-forming nucleic acids
N
105/00
Nucleic acids with catalytic activity, e.g. ribozymes
N
107/00
Nucleic acids involved in gene interference, e.g. siRNAs, microRNAs.